LR Health & Beauty SE announced its financial results for the second quarter and first half of 2026. The company is currently implementing measures that it deems crucial to its future success, including investments in production at its Ahlen site, optimizing for international growth and expanding in-house production to strengthen value creation and its ability to scale.
In the second quarter of 2026, revenue totaled $67 million, representing a 16.1% year-over-year decrease. During the first six months of 2026, revenue amounted to $138 million, a 17% year-over-year decline, with EBITDA of $4.5 million.
The company stated that sales performance “continued to be characterized by a challenging market environment, with consumer sentiment generally subdued.”
“With the successful completion of our financial realignment, we have already made significant progress in the transformation year 2026 towards positioning LR for the future,” said Jörg Körfer, LR Health & Beauty SE CEO. “On this basis, we are consistently driving forward our strategic initiatives, with a particular focus on developing the organization sustainably and enabling future growth at LR. At the same time, we are looking forward to the upcoming Business Days in September. They provide the ideal platform to further deepen our dialogue with our partner community, jointly advance our activities and provide important impetus for LR’s future.”
